EA000677B1 - Способ предотвращения остеопороза - Google Patents

Способ предотвращения остеопороза Download PDF

Info

Publication number
EA000677B1
EA000677B1 EA199700449A EA199700449A EA000677B1 EA 000677 B1 EA000677 B1 EA 000677B1 EA 199700449 A EA199700449 A EA 199700449A EA 199700449 A EA199700449 A EA 199700449A EA 000677 B1 EA000677 B1 EA 000677B1
Authority
EA
Eurasian Patent Office
Prior art keywords
alendronate
years
osteoporosis
dose
day
Prior art date
Application number
EA199700449A
Other languages
English (en)
Russian (ru)
Other versions
EA199700449A1 (ru
Inventor
Эшли Дж. Йэтс
Original Assignee
Мерк Энд Ко., Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Энд Ко., Инк. filed Critical Мерк Энд Ко., Инк.
Publication of EA199700449A1 publication Critical patent/EA199700449A1/ru
Publication of EA000677B1 publication Critical patent/EA000677B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA199700449A 1995-06-02 1996-05-29 Способ предотвращения остеопороза EA000677B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02
PCT/US1996/007912 WO1996038156A1 (en) 1995-06-02 1996-05-29 Use of alendronate for the prevention of osteoporosis

Publications (2)

Publication Number Publication Date
EA199700449A1 EA199700449A1 (ru) 1998-06-25
EA000677B1 true EA000677B1 (ru) 2000-02-28

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199700449A EA000677B1 (ru) 1995-06-02 1996-05-29 Способ предотвращения остеопороза

Country Status (21)

Country Link
EP (1) EP0828496A1 (bg)
JP (1) JPH10506648A (bg)
KR (1) KR19990022436A (bg)
CN (1) CN1192685A (bg)
AU (1) AU709196B2 (bg)
BG (1) BG63103B1 (bg)
BR (1) BR9609020A (bg)
CA (1) CA2222318A1 (bg)
CZ (1) CZ381197A3 (bg)
EA (1) EA000677B1 (bg)
EE (1) EE03306B1 (bg)
HU (1) HUP9900659A3 (bg)
IL (1) IL118422A0 (bg)
IS (1) IS4617A (bg)
NO (1) NO975527D0 (bg)
NZ (1) NZ308935A (bg)
PL (1) PL323669A1 (bg)
SK (1) SK159597A3 (bg)
TR (1) TR199701482T1 (bg)
WO (1) WO1996038156A1 (bg)
ZA (1) ZA964465B (bg)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
PT1392325E (pt) * 2001-05-02 2006-10-31 Novartis Ag Metodo de administracao de bifosfonatos por inalacao no tratamento ou na prevencao da reabsorcao ossea e da osteoporose
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および／または治療のための組成物、その組成物の調製方法およびその使用
KR102472749B1 (ko) * 2022-01-18 2022-12-02 주식회사 위엔씨 유해가스제거 및 항균탈취기능을 함유한 흡착소재 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
PL323669A1 (en) 1998-04-14
CA2222318A1 (en) 1996-12-05
TR199701482T1 (xx) 1998-03-21
NO975527L (no) 1997-12-01
JPH10506648A (ja) 1998-06-30
BR9609020A (pt) 1999-07-06
IS4617A (is) 1997-11-19
CZ381197A3 (cs) 1998-06-17
HUP9900659A3 (en) 2002-12-28
NZ308935A (en) 2000-07-28
BG102060A (bg) 1998-07-31
EE03306B1 (et) 2000-12-15
EP0828496A1 (en) 1998-03-18
EA199700449A1 (ru) 1998-06-25
KR19990022436A (ko) 1999-03-25
CN1192685A (zh) 1998-09-09
SK159597A3 (en) 1998-06-03
BG63103B1 (bg) 2001-04-30
ZA964465B (en) 1996-12-11
NO975527D0 (no) 1997-12-01
HUP9900659A2 (hu) 2001-04-28
AU5882496A (en) 1996-12-18
AU709196B2 (en) 1999-08-26
IL118422A0 (en) 1996-09-12
WO1996038156A1 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
FI118296B (fi) Oraalisia nestemäisiä alendronaattikokoonpanoja
EP0284612B1 (en) Treatment of bone loss
JP2004531468A5 (bg)
CA2151240A1 (en) Biophosphonate/estrogen therapy for treating and preventing bone loss
EA000964B1 (ru) Способ лечения или предупреждения остеопороза
AU690431B2 (en) Method of lessening the risk of non-vertebral bone fractures
TW200300091A (en) Dosage unit comprising a prostaglandin analog for treating constipation
TWI344367B (en) Use of zoledronic acid or a pharmaceutically acceptable salt or hydrate thereof in the preparation of a medicament for the treatment of osteoporosis post hip fracture
JPH01151515A (ja) 骨粗鬆症および関連障害の治療法
EA000677B1 (ru) Способ предотвращения остеопороза
US20020169148A1 (en) Use of alendronate for the prevention of osteoporosis
US5914099A (en) Prevention of tooth loss by the administration of alendronate or its salts
KR19980702209A (ko) 척추 골절의 위험을 경감시키는 방법
GB2197198A (en) Analgesic preparations
JPS63258414A (ja) 抗腫瘍剤
JP2616845B2 (ja) システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤
Standard Pr TEVA-RISEDRONATE
EP0691814B1 (en) Method and composition for treatment of osteoporosis
JPH0132804B2 (bg)
MXPA97009426A (en) Use of alendronate to prepare compositions for the prevention of osteoporo
EP0268868A2 (en) Pharmaceutical compositions for the treatment of gastro-intestinal diseases
MXPA97009906A (en) Use of bisphosphonates to prepare compositions to prevent loss of associated bone conterapia immunosupres
MXPA97006277A (en) The use of alendronate to prepare compositions to reduce the risk of non-vertebrate bit fractures

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU